15 · Public Calls Ledger

FDA approves BridgeBio’s BBP-418 for limb-girdle muscular dystrophy 2I/R9

Erasca says 44% of 25 responded; it’s Phase 1 · No. 052 · · About 1 min read

#
12
Call (resolves yes or no)
FDA approves BridgeBio’s BBP-418 for limb-girdle muscular dystrophy 2I/R9
By
11.27
Our odds
60%
Status
Open

Bookmarks need a Mind Club sign-in. How sign-in works

Read it in Public Calls Ledger